Business Context and Reporting Period
This Form 8-K is a current report filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata) on December 11, 2008. The filing discloses corporate governance changes, including the election of a new director and the execution of a new executive employment agreement.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and executive compensation arrangements.
Material Changes
- Board Expansion: The Board of Directors amended the Company's Bylaws to increase the number of directors from eight to nine.
- New Director Election: Steven Goldby was elected as a Class I Director and member of the Audit Committee.
- Executive Compensation Update: A new employment agreement was entered into with CEO Gary T. Steele, effective January 1, 2009.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, market outlook, or general management commentary regarding business operations. It details specific contractual terms for executive compensation:
- CEO Salary: Gary T. Steele's base salary is set at $375,000 annually through 2009 and increases to $450,000 annually from 2010 through 2011.
- Severance Provisions:
- Termination without cause/Good reason: 100% of annual base salary plus one-year acceleration of unvested equity and health insurance coverage until age 65.
- Change of Control (within 2 years): 150% of annual base salary plus health insurance coverage until age 65. All unvested equity immediately vests.
- Director Compensation: Steven Goldby received an option to purchase 10,000 shares (vesting monthly over 3 years) and 3,333 Restricted Stock Units (vesting fully on the third anniversary).
Investor Verification Checklist
- Verify the identity of the registrant as Landec Corporation, noting the discrepancy with the metadata label "LIFECORE BIOMEDICAL, INC."
- Review the attached Employment Agreement (Exhibit 10.26) for full details on performance goals and termination definitions.
- Confirm the impact of the new director on the composition of the Audit Committee.
- Assess the potential cash outflow implications of the CEO's severance package in the event of a change of control.